Business Wire

Veristat is Recognized on the Inc. 5000 List of America’s Fastest-Growing Private Companies for the 4th Consecutive Year

Del

Veristat, a full service Clinical Research Organization (CRO), proudly announces its recognition once again by Inc. Magazine as one of the 5000 fastest-growing private companies in the United States. Since its first appearance on the list in 2015, Veristat has accelerated its growth in size, geographic reach and ability to successfully guide clinical trials through the development process to regulatory approval.

“Veristat’s ability to achieve this national recognition and to remain on this list for 4 consecutive years highlights our sustainability, innovation and unfaltering commitment to consistently delivering the highest quality clinical development and regulatory submission services to our clients,” stated Patrick Flanagan, Chief Executive Officer at Veristat. “The meaningful impact that our teams provide to our clients and to lives of the patients their programs benefit is astounding. In 2018, our teams supported five regulatory submissions that were submitted to the US Food & Drug Administration (FDA) and Health Canada. Four of the submission projects which we previously supported received approval this year.”

Veristat strives to work collaboratively with biotechnology and pharmaceutical companies throughout the entire clinical development life cycle: from trial design all the way to regulatory approval. The Company plans to embark on an even more aggressive growth strategy in the coming year to further improve and expand our capabilities into new services offerings and geographies to pro-actively address the needs of our growing client base.

Inc. Magazine has been ranking the top 5000 fastest-growing private companies since 1982. Earning a spot on this list is a milestone achievement. The list represents risk-takers and entrepreneurs that build something great from the ground up, a feat many cannot say they have accomplished. According to INC.com, this year’s fastest-growing companies in America are a force, notching collective revenue of more than $206.2 billion in 2017 and three-year revenue growth rates that reach 75,661 percent. To learn more, view the 2018 Inc. 5000 List.

About Veristat:

Veristat is a clinical research partner focused on supporting biopharmaceutical firms as they advance their therapies through the clinical development and regulatory submission process. Our work delivers meaningful clinical impact and our regulatory submission expertise is unrivaled in our industry. Veristat teams have supported over 70 regulatory submission projects that have resulted in more than 40 submission approvals to date from various regulatory agencies around the world. We work collaboratively with clients to create a personalized project team of collaborative problem-solvers based on their therapy area and clinical development needs. Veristat aims is to propel even the most complex submissions to successful regulatory conclusions so that new therapies become available to improve and save lives. For more information on our impactful strategic consulting, data analysis, clinical trial management or regulatory submission expertise, visit www.veristat.com.

Contact information

Veristat Contact:
Gillian Dellacioppa, 508-306-6336
Marketing Director
gillian.dellacioppa@veristat.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Arthur D. Little Appoints Michael Kruse as Head of Global Energy & Utilities Practice23.4.2019 09:42:00 CESTPressemelding

Arthur D. Little (ADL) today announced the appointment of Michael Kruse as the new Global Practice Leader for its Global Energy & Utilities practice. A Partner based in ADL’s Frankfurt office, Michael has been with the company for over 11 years, focusing on the strategy and project development behind large-scale capital investment programs in the power sector, including conventional and renewable energies, as well as power grids. His most recent consulting work explored the future of nuclear generation, offshore wind and corporate transformation in the digital era. ADL’s Global Energy and Utilities practice works together with its clients as partners to apply clear thinking to their key strategic issues. It offers a unique ability to combine four factors: a deep, practical understanding of the energy industry and its most difficult challenges, the highest caliber of people, innovation to produce fresh insight, and a commitment to achieving measurable results. Ignacio García Alves, Chai

The New myPOS Go is Here to Become a Market Leader at Just 29 EUR23.4.2019 09:25:00 CESTPressemelding

Europe’s fastest growing payments provider, myPOS, today announces the upcoming launch of its latest payment terminal - myPOS Go. Portable and light-weighted, myPOS Go boasts a list of innovative functionalities, emblematic for all myPOS devices – from accepting cards and mobile wallets to sending payment requests and topping up prepaid phones and branded gift cards. At just 29 EUR, merchants will get the new payment device with a free myPOS account and business debit card to it for immediate use of the acquired funds, which are settled instantly after every received payment. The payment terminal is pocket-sized, paperless and perfect for merchants on the go, who seek independence from traditional banks. "Designing payment services with the small and micro businesses in mind, we are aware that some merchants are really sensitive to the cost of payment terminals. Although we do not charge any monthly fees in addition to the device cost, we would like to cater to those merchants and offe

Samsung Sets New Photon Efficacy Level in White LED Packages for Indoor Farms23.4.2019 09:00:00 CESTPressemelding

Samsung Electronics Co., Ltd., a world leader in advanced digital component solutions, today announced an industry-leading enhancement to its mid-power LED package – the LM301H – for horticulture applications, such as greenhouse and vertical farming*. At 3.10 micromoles per joule (μmol/J), the newly introduced LM301H now features the highest photon efficacy** among today’s mid-power white LED packages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190423005400/en/ Samsung Horticulture LED LM301H (Photo: Business Wire) “This breakthrough in photon efficacy will go a long way in helping indoor farm owners to maximize plant growth and quality, as well as their profits,” said Un Soo Kim, senior vice president of LED Business Team at Samsung Electronics. “We are committed to continue innovating white LED solutions optimized for healthier plant production as we solidify our leadership in the horticulture lighting industry.” As a

Vivet Therapeutics Announces 2 Abstracts Accepted for Oral Presentation at 2019 American Society of Gene and Cell Therapy Annual Meeting23.4.2019 08:38:00 CESTPressemelding

Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments for inherited liver disorders with high unmet medical need, today announced that new data from its lead development program, VTX-801 a novel investigational gene therapy for WD, and VTX-803, Vivet’ novel therapeutic in development for the treatment of PFIC3, have been accepted for oral presentation during the ASGCT 22nd Annual Meeting, April 29 - May 2, 2019 in Washington, D.C., USA. Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO & Head of the Gene Therapy Dept. at FIMA will present data from a recently completed study, validating in WD mice the use of fecal excretion of IV-injected 64copper as a pharmacodynamic endpoint in the VTX-801 Phase I/II trial currently under preparation. These data are the first demonstration of copper homeostasis restoration with 64Copper in an animal model of WD through the delivery of a single, intravenous administration of

Transphorm Centers on the Simplicity and Reliability of High Voltage GaN Application Development at PCIM 201923.4.2019 08:00:00 CESTPressemelding

Transphorm Inc.—the leader in the design and manufacturing of the highest reliability and first JEDEC- and AEC-Q101 qualified 650 V and 900 V gallium nitride (GaN) semiconductors—today shared a glimpse into its 2019 PCIM Europe showcase. Located in Hall 9 Booth 519, it centers on three key points to help conference attendees better understand Transphorm’s high voltage GaN value proposition: Reliability: Design with confidence when using Transphorm’s high quality, high reliability (Q+R) GaN transistors. Drivability: Pair Transphorm’s devices with off-the-shelf drivers, for easing drivability. Simplicity: Experience simpler designs due to minimal external gate drive circuitry along with standard packages, such as TO-220, TO-247, and PQFN, with well-known thermal management techniques. “At PCIM, you’ll see the culmination of Transphorm’s innovation along with its measurable impact on low volume as well as high volume customer applications,” said Philip Zuk, Vice President, Technical Marke

PV InfoLink to Host Dialogues with Industry Heavyweights on 2H19 Solar Market Outlook Prior To SNEC23.4.2019 07:00:00 CESTPressemelding

A seminar titled “2H19 PV Market Outlook and Forecast” will be held in Shanghai on June 3, one day prior to SNEC, to discuss global supply chain market outlook in the second half of this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190423005391/en/ 2019 Module Prices and Demand Forecast. (Photo: Business Wire) Held by PV InfoLink, a leading solar market intelligence provider, the seminar will bring together PV manufacturers, developers, EPC, and investors to explore major issues revolving the industry and help participants gain valuable insights for navigating the expanding solar market. PV InfoLink has invited Chinese major companies, including Jinko, Longi, and GCL-Si, to discuss impact of China’s transition to a subsidy-free market. This year, China’s demand will revive later than usual due to policy uncertainty. Moreover, Japan and India, China’s two major trading partners, saw weakening demand after the end of f